GeneReach Biotechnology Corp. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 258.494 million compared to TWD 77.161 million a year ago. Operating income was TWD 125.409 million compared to TWD 23.195 million a year ago. Net income was TWD 84.765 million compared to TWD 23.464 million a year ago. Basic earnings per share was TWD 2.09 compared to TWD 0.63 a year ago. Diluted earnings per share was TWD 2.09 compared to TWD 0.6 a year ago. For the half year, sales was TWD 387.833 million compared to TWD 163.513 million a year ago. Operating income was TWD 149.368 million compared to TWD 49.665 million a year ago. Net income was TWD 97.997 million compared to TWD 43.935 million a year ago. Basic earnings per share was TWD 2.41 compared to TWD 1.2 a year ago. Diluted earnings per share was TWD 2.41 compared to TWD 1.12 a year ago.